UK markets open in 3 hours 41 minutes
NIKKEI 225
38,688.66 +452.59 (+1.18%) HANG SENG
18,446.64 -131.66 (-0.71%) CRUDE OIL
78.76 +0.28 (+0.36%) GOLD FUTURES
2,332.20 +1.00 (+0.04%) DOW
38,852.27 +176.59 (+0.46%) Bitcoin GBP
50,722.12 -81.20 (-0.16%)
Viveve Medical, Inc. (VIVE)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:15PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.22k |
| Enterprise value | -22.78k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.00 |
| Price/book (mrq) | 0.00 |
| Enterprise value/revenue | -0.00 |
| Enterprise value/EBITDA | 0.00 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.14 |
| 52-week change 3 | -99.37% |
| S&P500 52-week change 3 | 24.49% |
| 52-week high 3 | 0.1107 |
| 52-week low 3 | 0.0001 |
| 50-day moving average 3 | 0.0002 |
| 200-day moving average 3 | 0.0012 |
Share statistics
| Avg vol (3-month) 3 | 2.99k |
| Avg vol (10-day) 3 | 2.07k |
| Shares outstanding 5 | 10.72M |
| Implied shares outstanding 6 | 10.72M |
| Float 8 | 10.72M |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 0.00% |
| Shares short (30 Dec 2022) 4 | 374.24k |
| Short ratio (30 Dec 2022) 4 | 4.15 |
| Short % of float (30 Dec 2022) 4 | 3.49% |
| Short % of shares outstanding (30 Dec 2022) 4 | 3.49% |
| Shares short (prior month 30 Nov 2022) 4 | 178.07k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 02 Dec 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 02 Dec 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2021 |
| Most-recent quarter (mrq) | 30 Sept 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -276.84% |
Management effectiveness
| Return on assets (ttm) | -62.13% |
| Return on equity (ttm) | -210.99% |
Income statement
| Revenue (ttm) | 6.83M |
| Revenue per share (ttm) | 0.64 |
| Quarterly revenue growth (yoy) | 4.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -20.34M |
| Net income avi to common (ttm) | -28.14M |
| Diluted EPS (ttm) | -3.9700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 5.91M |
| Total cash per share (mrq) | 0.55 |
| Total debt (mrq) | 6.01M |
| Total debt/equity (mrq) | 507.94% |
| Current ratio (mrq) | 0.89 |
| Book value per share (mrq) | 0.11 |
Cash flow statement
| Operating cash flow (ttm) | -16.23M |
| Levered free cash flow (ttm) | -7.58M |
© 2024 Yahoo. All rights reserved.